BUTITTA CYNTHIA M 4

What Happened

• Cynthia M. Butitta, a director of Autolus Therapeutics plc (AUTL), received two RSU awards on June 29, 2026: 31,667 RSUs and 47,500 RSUs, for a total of 79,167 restricted stock units. The reported price is $0.00, indicating these were awards/grants (derivative awards), not cash purchases or sales.

Key Details

• Transaction date: 2026-06-29; Form 4 filed: 2026-07-01 (filed within the standard two-business-day window).
• Awards: 31,667 RSUs and 47,500 RSUs (total 79,167 RSUs); reporting shows acquisition code A (award/grant) and $0.00 per share.
• Shares owned after transaction: not specified in the filing.
• Footnotes of note:
  • F1: Each RSU represents a contingent right to one American Depositary Share (ADS); each ADS is convertible at the reporting person's option into one Ordinary Share.
  • F2: The RSUs vest in one installment on June 29, 2027.
  • F3: The filing also notes that any share options (if applicable) vest in 12 equal monthly installments beginning July 29, 2026.
• Filing timeliness: Filed July 1, 2026, which is within the typical Form 4 filing deadline following a 2026-06-29 transaction.

Context

• These are equity compensation awards (RSUs) that represent future delivery of ADSs/ordinary shares upon vesting; no cash changed hands at grant. RSU grants are common as part of director compensation and do not by themselves indicate immediate buying or selling of stock.